Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 21 - 30 of 57 for hd. (0.05 seconds)

CBT 200 Scores A Win. More details...
CBT 200 Drops 1.5%. More details...
CBT 200 Drops 26 Points. More details...
CBT 200 Gives Up 23 Points. More details...
CBT 200 Takes 48 Point Hit. More details...
CBT 200 Adds On 32 Points. More details...
CBT 200 Slips 3 Points Lower. More details...
HDL Space Supposed To Belong To Pfizer....
CBT 200 Closes With 10 Point Gain. More details...
CBT 200 Climbs 19 Points Higher. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital